About this event

Schedule III doesn’t just change your tax bracket; it changes the rules of the game. It signals a shift toward a pharmaceutical reality where process validation is the new standard. In the eyes of federal regulators, if you didn’t document it, it didn’t happen.

This webinar cuts through the hype to focus on the operational impact of rescheduling. We’ll break down what operators can expect when "craft" meets compliance, including

- The Oversight Shift: Trading the IRS for the FDA, and what regulators actually prioritize.

- Operational Blind Spots: The gaps in your SOPs that could leave your facility vulnerable.

- The Data Defense: Why consistency is your only currency, and how AROYA growers are already ahead of the curve.

‍

Join us for a pragmatic roadmap on how to professionalize your facility before the regulations force your hand. If you want to prepare for a world where "vibes" won’t pass inspection, you need to be here. Control the shift, control the game.

‍